Reset Map上海市浦东新区达尔文路88号11号楼1、3楼 Floor 3, building 11, No. 88 Darwin Road, Pudong New Area, Shanghai 上海Shanghai, 上海Shanghai, 200000 China上海澳能生物技术有限公司(OriBiotech)总部位于上海张江药谷,在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来,秉持着以信誉为立身之本,从细节处着眼的精神,始终专注于肿瘤免疫及原代细胞领域,拥有一系列基于原代免疫细胞的临床前药物开发,以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务;免疫药效实验材料筛选服务;承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系,真正做到细胞生产及药效服务各环节的全过程控制,为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴,提供高质量的产品和标准化的服务,助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.
上海市浦东新区达尔文路88号11号楼1、3楼 上海, 上海, 201203 China上海澳能生物技术有限公司(OriBiotech)总部位于上海张江药谷,在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来,秉持着以信誉为立身之本,从细节处着眼的精神,始终专注于肿瘤免疫及原代细胞领域,拥有一系列基于原代免疫细胞的临床前药物开发,以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务;免疫药效实验材料筛选服务;承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系,真正做到细胞生产及药效服务各环节的全过程控制,为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴,提供高质量的产品和标准化的服务,助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.
Floor 3, building 11, No. 88 Darwin Road, Pudong New Area, Shanghai Shanghai, Shanghai, 201203 China上海澳能生物技术有限公司(OriBiotech)总部位于上海张江药谷,在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来,秉持着以信誉为立身之本,从细节处着眼的精神,始终专注于肿瘤免疫及原代细胞领域,拥有一系列基于原代免疫细胞的临床前药物开发,以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务;免疫药效实验材料筛选服务;承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系,真正做到细胞生产及药效服务各环节的全过程控制,为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴,提供高质量的产品和标准化的服务,助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.
Floor 1 & 3, Building 11, No. 88 Darwin Road, Pudong New Area, Shanghai Shanghai, Shanghai, 201203 China上海澳能生物技术有限公司(OriBiotech)总部位于上海张江药谷,在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来,秉持着以信誉为立身之本,从细节处着眼的精神,始终专注于肿瘤免疫及原代细胞领域,拥有一系列基于原代免疫细胞的临床前药物开发,以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务;免疫药效实验材料筛选服务;承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系,真正做到细胞生产及药效服务各环节的全过程控制,为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴,提供高质量的产品和标准化的服务,助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.
Floor 1, Building 11, No. 88 Darwin Road, Pudong New Area, Shanghai Shanghai, Shanghai, 201203 China上海澳能生物技术有限公司(OriBiotech)总部位于上海张江药谷,在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来,秉持着以信誉为立身之本,从细节处着眼的精神,始终专注于肿瘤免疫及原代细胞领域,拥有一系列基于原代免疫细胞的临床前药物开发,以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务;免疫药效实验材料筛选服务;承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系,真正做到细胞生产及药效服务各环节的全过程控制,为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴,提供高质量的产品和标准化的服务,助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.